• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型肽药物递送系统的开发及体内特征研究,该系统可提供延长的血浆半衰期。

Development and in vivo characterization of a novel peptide drug delivery system providing extended plasma half life.

机构信息

Department of Pharmaceutical Technology, Institute of Pharmacy, University of Innsbruck, Innrain 52c, Josef Möller Haus, 6020 Innsbruck, Austria.

出版信息

J Control Release. 2012 Feb 10;157(3):375-82. doi: 10.1016/j.jconrel.2011.09.092. Epub 2011 Oct 1.

DOI:10.1016/j.jconrel.2011.09.092
PMID:21986100
Abstract

It was the aim of this study to develop a sustained parenteral peptide (DALCE) delivery system by the immobilization of DALCE to thiolated carboxymethyl dextran-cysteine (CMD-Cys) via disulfide bond formation. The resulting CMD-Cys-DALCE conjugate displayed a 22.6±7.9% (m/m) of DALCE (mean±S.D.; n=3). The conjugation of DALCE with CMD-Cys was confirmed by FTIR-ATR spectroscopy. In vitro release studies of conjugate CMD-Cys-DALCE in the presence of 2 μM/ml reduced glutathione (GSH) being also available in the plasma showed a sustained peptide release over a time period of 8 h, because of thiol/disulfide exchange reactions. For in vivo pharmacokinetic study, DALCE and CMD-Cys-DALCE were administered intravenously to male Sprague-Dawley rats at a dose of 1mg/kg. The AUC(0-8) (ng.min/ml) was determined to be 268848±924 and 40019±495 for CMD-Cys-DALCE and DALCE, respectively. The mean residence time (MRT) was determined to be 256±8 and 53.1±9.5 min for CMD-Cys-DALCE and for DALCE, respectively. CMD-Cys-DALCE showed a more than 5-fold increased elimination half-life (p<0.01), 3-fold decreased volume of distribution (p<0.01) and a 6.7-fold decreased plasma clearance rate (p<0.01) compared to DALCE. According to these findings, CMD-Cys-DALCE seems to act as prodrug by improving half-life and decreasing plasma clearance.

摘要

本研究旨在通过二硫键将 DALCE 固定到巯基化羧甲基葡聚糖-半胱氨酸(CMD-Cys)上来开发一种持续的肠外肽(DALCE)递送系统。所得的 CMD-Cys-DALCE 缀合物显示出 22.6±7.9%(m/m)的 DALCE(平均值±S.D.;n=3)。通过傅里叶变换衰减全反射(FTIR-ATR)光谱证实了 DALCE 与 CMD-Cys 的缀合。在存在 2 μM/ml 还原型谷胱甘肽(GSH)的情况下,还可以在血浆中获得的缀合物 CMD-Cys-DALCE 的体外释放研究表明,由于硫醇/二硫键交换反应,肽可以持续释放 8 小时。对于体内药代动力学研究,以 1mg/kg 的剂量将 DALCE 和 CMD-Cys-DALCE 静脉内给予雄性 Sprague-Dawley 大鼠。分别确定 AUC(0-8)(ng.min/ml)为 268848±924 和 40019±495 用于 CMD-Cys-DALCE 和 DALCE。分别确定平均驻留时间(MRT)为 256±8 和 53.1±9.5 min 用于 CMD-Cys-DALCE 和 DALCE。与 DALCE 相比,CMD-Cys-DALCE 显示出消除半衰期增加了 5 倍以上(p<0.01),分布容积降低了 3 倍(p<0.01),血浆清除率降低了 6.7 倍(p<0.01)。根据这些发现,CMD-Cys-DALCE 通过提高半衰期和降低血浆清除率似乎起到前药的作用。

相似文献

1
Development and in vivo characterization of a novel peptide drug delivery system providing extended plasma half life.新型肽药物递送系统的开发及体内特征研究,该系统可提供延长的血浆半衰期。
J Control Release. 2012 Feb 10;157(3):375-82. doi: 10.1016/j.jconrel.2011.09.092. Epub 2011 Oct 1.
2
Enhancement of anti-tumor activity of hybrid peptide in conjugation with carboxymethyl dextran via disulfide linkers.通过二硫键连接子将杂合肽与羧甲基葡聚糖偶联以增强其抗肿瘤活性。
Eur J Pharm Biopharm. 2015 May;92:228-36. doi: 10.1016/j.ejpb.2015.03.015. Epub 2015 Mar 20.
3
Synthesis, characterization, mucoadhesion and biocompatibility of thiolated carboxymethyl dextran-cysteine conjugate.巯基化羧甲基葡聚糖-半胱氨酸偶联物的合成、表征、黏附性和生物相容性。
J Control Release. 2010 May 21;144(1):32-8. doi: 10.1016/j.jconrel.2010.01.033. Epub 2010 Jan 31.
4
Extending insulin action in vivo by conjugation to carboxymethyl dextran.通过与羧甲基葡聚糖结合在体内延长胰岛素作用。
Bioconjug Chem. 1998 Mar-Apr;9(2):176-83. doi: 10.1021/bc970180a.
5
Characterization of D-Ala2,Leu5,Cys6-enkephalin: a novel synthetic opioid peptide with slowed dissociation from delta receptors.D-丙氨酸2、亮氨酸5、半胱氨酸6-脑啡肽的特性:一种从δ受体解离缓慢的新型合成阿片肽。
NIDA Res Monogr. 1986;75:193-6.
6
Opioid agonist and antagonist antinociceptive properties of [D-Ala2,Leu5,Cys6]enkephalin: selective actions at the deltanoncomplexed site.[D-丙氨酸2,亮氨酸5,半胱氨酸6]脑啡肽的阿片样激动剂和拮抗剂的抗伤害感受特性:在δ非复合位点的选择性作用。
J Pharmacol Exp Ther. 1990 Nov;255(2):636-41.
7
Thiomers in noninvasive polypeptide delivery: in vitro and in vivo characterization of a polycarbophil-cysteine/glutathione gel formulation for human growth hormone.硫醇聚合物在无创多肽递送中的应用:用于人生长激素的聚卡波非-半胱氨酸/谷胱甘肽凝胶制剂的体外和体内特性研究
J Pharm Sci. 2004 Jul;93(7):1682-91. doi: 10.1002/jps.20069.
8
Thiolated polycarbophil/glutathione: defining its potential as a permeation enhancer for oral drug administration in comparison to sodium caprate.巯基化聚卡波非/谷胱甘肽:与癸酸钠相比,定义其作为口服药物给药渗透增强剂的潜力。
Drug Deliv. 2011 Aug;18(6):415-23. doi: 10.3109/10717544.2011.570807. Epub 2011 May 9.
9
Effect of chemical modification on the pharmacokinetics and biodistribution of carboxymethyl dextran as a drug carrier.化学修饰对作为药物载体的羧甲基葡聚糖的药代动力学和生物分布的影响。
Drug Deliv. 2002 Jul-Sep;9(3):187-93. doi: 10.1080/15227950290097624.
10
[Magnetic drug delivery system--adriamycin-carboxymethyl dextran magnetic nanoparticles].[磁性药物递送系统——阿霉素-羧甲基葡聚糖磁性纳米颗粒]
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2000 Mar;17(1):21-4.

引用本文的文献

1
Impact of Conjugation Chemistry on the Pharmacokinetics of Peptide-Polymer Conjugates in a Model of Traumatic Brain Injury.共轭化学对创伤性脑损伤模型中肽-聚合物共轭物药代动力学的影响。
Bioconjug Chem. 2025 Jul 16;36(7):1483-1493. doi: 10.1021/acs.bioconjchem.5c00175. Epub 2025 Jun 27.
2
Cleavage-Responsive Biofactory T Cells Suppress Infectious Diseases-Associated Hypercytokinemia.可裂解型生物工厂 T 细胞抑制感染性疾病相关的细胞因子血症。
Adv Sci (Weinh). 2022 Sep;9(26):e2201883. doi: 10.1002/advs.202201883. Epub 2022 Jun 25.
3
Impact of physiochemical properties on pharmacokinetics of protein therapeutics.
物理化学性质对蛋白质治疗药物药代动力学的影响。
Eur J Drug Metab Pharmacokinet. 2013 Dec;38(4):231-9. doi: 10.1007/s13318-013-0126-0. Epub 2013 Apr 14.